|
US2016103973A1
|
|
Computer-implemented system and method for identifying similar patients
|
|
AU2015364605A1
|
|
Computer-implemented system and method for identifying similar patients
|
|
WO2015066452A2
|
|
Methods of treating pediatric cancers
|
|
WO2015066432A1
|
|
Methods of treating post-myeloproliferative neoplasms (mpns) and post-mpn acute myeloid leukemia
|
|
WO2015066439A2
|
|
Methods of treating hematological malignancies
|
|
US2015046191A1
|
|
System and method for managing genomic information
|
|
US2015046180A1
|
|
System and method for managing genomic information
|
|
EP2945652A2
|
|
Methods of treating cholangiocarcinoma
|
|
EP2941753A1
|
|
System and method for outcome tracking and analysis
|
|
AU2013337264A1
|
|
Novel fusion molecules and uses thereof
|
|
AU2013337277A1
|
|
Novel NTRK1 fusion molecules and uses thereof
|
|
CA2880764A1
|
|
Human papilloma virus as predictor of cancer prognosis
|
|
AU2013286635A1
|
|
Tm-enhanced blocking oligonucleotides and baits for improved target enrichment and reduced off-target selection
|
|
WO2013059740A1
|
|
Novel alk and ntrk1 fusion molecules and uses thereof
|
|
WO2013056178A2
|
|
Novel estrogen receptor mutations and uses thereof
|
|
SG2014012728A
|
|
Novel kif5b-ret fusion molecules and uses thereof
|
